The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

When Lea Hughes first spotted a small lump on her breast she was reassured it was just due to 'hormones'. But two years later ...

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...

By 2030, Daiichi Sankyo aims to have five different ADC therapies approved for use in more than 30 types of cancer. To support this, it is running over 60 clinical trials across Europe and Canada in ...

SIX artificial intelligence (AI) models recently went head-to-head with seasoned equity analysts to produce Swot (strengths, ...

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Merck's growing pipeline, with nearly 20 new launches ahead, is set to reshape its portfolio as Keytruda's 2028 patent expiry ...

Lea first spotted a small lump on her right breast but was reassured her 'lumpy boobs' were just due to hormones ...

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...

A Brit woman was given a shocking diagnosis of stage 4 breast cancer after she said her tumour was repeatedly dismissed as ...